Vaccination Policy: It is a health policy that the government adopts for the process of vaccination. Vaccination policies have been developed over the approximately two centuries since the invention of vaccinations with the motive of suppress disease from, or boost a strong immunity system for, the population the government wants to protect. When EPI was established over 40 years ago, its main focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed completely When EPI was established over 40 years ago, its focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed dramatically.
Regulatory Affairs: Although the European Medicines Agency (EMA) and the World Health Organization (WHO) and the United States Food and Drug Administration (USFDA), already must established a Regulatory framework for the guideline for vaccines, the other region across the world are still at a nascent period in creating a Regulatory framework for vaccines at a national level in their own countries. As regulatory compliance for all vaccines requires some special sets of hands-on functional experience and Regulatory expertise knowledge, organizations may find it challenging to navigate through the global Regulatory framework for Vaccines.
Title : Vaccines and monoclonal antibodies in the prolonged treatment of non-small cell lung cancer: 20 years of follow-up
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Observational study post emergency use authorization of itolizumab in the treatment of COVID-19
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Vaccine for AML: 2023 and beyond
Stefan Gluck, Jessica McDonough PhD Co-Founder Attivare, United States
Title : Purification process development of COVID antigens to identify sera needed for plasma therapy
Sushmita Koley, Senior Scientist Bio-Rad Laboratories, United States
Title : Lessons that can be learned from the rollout of the COVID-19 vaccine and the acceptance of vaccination from healthcare professionals, frontline workers and patients that need to be considered in developing a vaccine
Regina Au, BioMarketing insight, United States
Title : Lessons learned for the future of social listening to address vaccine misinformation
Joseph Smyser, The Public Good Projects, United States
Title : Why Low-Energy-Electron Irradiation might be a potential game changer for vaccine development, manufacturing, and pandemics prevention
Daniel Becker, KyooBe Tech GmbH, Germany
Title : National immunization management system- NIMS
Kashif Zulfiqar, Project Manager - NADRA, Pakistan
Title : Medicinal synthetic aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4?2Al2 Mg3 (SiO4)3} effective for: Viral diseases; Tumors; Antimicrobial resistant infections
Maduike Chiehiura Onwubiko Ezeibe, Michael Okpara University of Agriculture, Nigeria
Title : Moving the needle for covid-19 vaccinations in Nigeria through leadership, accountability, and transparency
Fejiro Chinye Nwoko, Nigeria Solidarity Support Fund, Nigeria